Asthma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 18 years of age or older at the time of joining the trial
- People who have given written consent to participate, signed and dated, before the trial begins
- People who have been diagnosed with mild or moderate asthma that is not well controlled, based on a standard asthma scoring system called GINA
- People who have at least 52 weeks (about one year) of medical records available before joining the trial
Who may not be able to join:
- People who have severe asthma, or who are currently receiving or have received a biological therapy (a type of advanced medication) within the past 52 weeks
- People who currently have, or have previously had, chronic obstructive pulmonary disease (a long-term lung condition that makes breathing difficult) or idiopathic pulmonary fibrosis (a condition involving scarring of the lungs)
- People who are currently participating in another clinical trial, or who have done so within the past 52 weeks
- People who have any other acute or ongoing illness that the trial doctor believes would affect their ability to take part or could affect the trial results (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 1-877-240-9479
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To describe the baseline demographic characteristics of outpatients with uncontrolled asthma in the Russian Federation in all patients and in the cohort of patients receiving fixed-dose combination (FDC) budesonide/salbutamol on Visit 2; To describe the baseline clinical characteristics of outpatients with uncontrolled asthma in the Russian Federation in all patients and in the cohort of patients receiving FDC budesonide/salbutamol on Visit 2; To characterise the profile of routine therapy used for outpatients with uncontrolled asthma in the Russian Federation in all patients and in the cohort...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.